Filing Flows › Fortress Biotech (FBIO) › R&D spending
Fortress Biotech (FBIO) R&D spending by quarter
Fortress Biotech's R&D spending was $805K in Q2 2026 (second quarter 2026), +49% from Q1 2026. Over the last 6 quarters it ranged from $208K (Q3 2025) to $9.7M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $805K | +49% | -90% |
| Q1 2026 | $540K | +160% | -86% |
| Q3 2025 | $208K | -97% | — |
| Q2 2025 | $8.1M | +106% | — |
| Q1 2025 | $3.9M | -59% | — |
| Q4 2024 | $9.7M | — | — |
Q2 2026 at a glance
Fortress Biotech, Q2 2026: revenue $18.7M (+14% year over year), operating margin -53.5%, net earnings $602K, operating cash flow −$59.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Fortress Biotech's R&D spending?
Fortress Biotech's R&D spending was $805K in Q2 2026 (second quarter 2026), +49% from Q1 2026.
How has Fortress Biotech's R&D spending changed?
Over the last 6 quarters it ranged from $208K (Q3 2025) to $9.7M (Q4 2024).